Can MitoTEMPO protect rat sciatic nerve against ischemia-reperfusion injury?


Tuncer S., Akkoca A., Celen M. C., Dalkilic N.

Naunyn-Schmiedeberg's archives of pharmacology, cilt.394, ss.545-553, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 394
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s00210-020-02039-1
  • Dergi Adı: Naunyn-Schmiedeberg's archives of pharmacology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, Chimica, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.545-553
  • Anahtar Kelimeler: MitoTEMPO, Sciatic nerve, Ischemia-reperfusion, Conduction velocity distribution, CONDUCTION-VELOCITY DISTRIBUTIONS, ISCHEMIA/REPERFUSION INJURY, LIPID-PEROXIDATION, SCHWANN-CELL, FIBER, TEMPOL, MODELS, MUSCLE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Abdominal ischemia-reperfusion (I/R) is known to cause both structural and functional damage to sciatic nerve which is related to the oxidative stress. We investigated the protective effects of mitochondria-targeted antioxidant (2-(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl) triphenylphosphonium chloride (MitoTEMPO) on ischemia-reperfusion-induced nerve damage by using the conduction velocity distribution (CVD) calculations from in vitro compound nerve action potential (CNAP) recordings from rat sciatic nerve. Adult male Wistar albino rats were divided into three groups. The IR and IR + MT groups had aortic cross-clamping for 1 h followed by 2 h reperfusion, while SHAM group had the same procedure without cross-clamping. IR + MT group received 0.7 mg/kg/day MitoTEMPO injection for 28 days before I/R, while other groups received vehicle alone. Ischemia-reperfusion resulted in a significant decrease (p < .05) in maximum depolarizations (mV), areas (mV.ms), and maximum and minimum upstroke velocities (mV/ms) of CNAPs, while injection of MitoTEMPO showed a complete protective effect on these impairments. The histograms for CVD showed that I/R blocked the contribution of fast-conducting fibers (> 60 m/s). MitoTEMPO prevented that blockage and caused a shift in the CVD. Functional nerve damage caused by I/R can be prevented by MitoTEMPO, which can enter mitochondria, the main source of reactive oxygen species (ROS).